{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:24:24Z","timestamp":1758446664349,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.xphs.2021.12.013","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T11:18:55Z","timestamp":1639653535000},"page":"1911-1917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Considerations for Defining the Intravenous Administration Procedure for Nano-dose Sterile Drug Product in Clinical Studies"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9974-7264","authenticated-orcid":false,"given":"Michael","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshama","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-6200","authenticated-orcid":false,"given":"Gossett","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Travis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pete","family":"Skrdla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2021.12.013_bib0001","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/0016-5085(78)90079-3","article-title":"Binding of secretin to plastic surfaces","volume":"75","author":"Bitar","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xphs.2021.12.013_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122419","article-title":"Adsorption of cationic peptides to solid surfaces of glass and plastic","volume":"10","author":"Kristensen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2021.12.013_bib0003","first-page":"91","article-title":"Evaluation of various substances to prevent adsorption of tuberculin purified protein derivative (PPD) to glass surfaces","volume":"43","author":"Landi","year":"1970","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.xphs.2021.12.013_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1472-765X.1995.tb01089.x","article-title":"Adsorption of nisin and enterocin 4 to polypropylene and glass surfaces and its prevention by Tween 80","volume":"21","author":"Nu\u00f1ez","year":"1995","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.xphs.2021.12.013_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0378-5173(83)90055-8","article-title":"Adsorption of d-Nal(2) LHRH, a decapeptide, onto glass and other surfaces","volume":"16","author":"Anik","year":"1983","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.12.013_bib0006","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1039\/b612140c","article-title":"PDMS absorption of small molecules and consequences in microfluidic applications","volume":"6","author":"Toepke","year":"2006","journal-title":"Lab Chip"},{"key":"10.1016\/j.xphs.2021.12.013_bib0007","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2016.11.062","article-title":"Small molecule absorption by PDMS in the context of drug response bioassays","volume":"482","author":"van Meer","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.xphs.2021.12.013_bib0008","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s10439-012-0562-z","article-title":"Quantitative analysis of molecular absorption into PDMS microfluidic channels","volume":"40","author":"Wang","year":"2012","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.xphs.2021.12.013_bib0009","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2146\/ajhp140098","article-title":"In-use physicochemical and microbiological stability of biological parenteral products","volume":"72","author":"Ricci","year":"2015","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.xphs.2021.12.013_bib0010","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1002\/jps.23224","article-title":"Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags","volume":"101","author":"Kumru","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2021.12.013_bib0011","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.xphs.2019.07.021","article-title":"Overcoming challenges of implementing closed system transfer device clinical in-use compatibility testing for drug development of antibody drug conjugates","volume":"109","author":"Petoskey","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2021.12.013_bib0012","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0003-2697(88)90215-1","article-title":"Chemical degradation of 3H-labeled substance P in tris buffer solution","volume":"173","author":"Higa","year":"1988","journal-title":"Anal Biochem"},{"key":"10.1016\/j.xphs.2021.12.013_bib0013","first-page":"31","article-title":"Evaluation of the dead volume in intravenous short-term infusion","volume":"16","author":"Herbert Plagge","year":"2010","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.xphs.2021.12.013_bib0014","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1016\/j.xphs.2020.07.031","article-title":"Determination of holdup volume and transient contact compatibility of closed system transfer devices for a reconstituted lyophilized drug product","volume":"109","author":"Kagdi","year":"2020","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921006912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921006912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:38:57Z","timestamp":1758361137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921006912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0022354921006912"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.12.013","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations for Defining the Intravenous Administration Procedure for Nano-dose Sterile Drug Product in Clinical Studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}